In-Vitro Product Performance of Parenteral Drug Products: View of the USP Expert Panel

IF 1 4区 医学 Q4 PHARMACOLOGY & PHARMACY Dissolution Technologies Pub Date : 2022-01-01 DOI:10.14227/dt290422p204
D. D'Arcy, M. Wacker, S. Klein, Vivek Shah, M. D. Burke, G. Hunter, Hao Xu
{"title":"In-Vitro Product Performance of Parenteral Drug Products: View of the USP Expert Panel","authors":"D. D'Arcy, M. Wacker, S. Klein, Vivek Shah, M. D. Burke, G. Hunter, Hao Xu","doi":"10.14227/dt290422p204","DOIUrl":null,"url":null,"abstract":"Performance testing of parenteral products represents a broad arena of product types, test equipment, and analytical challenges. This Stimuli article is one in a series of Stimuli articles on product performance testing focused on common methodological approaches used and challenges encountered in the field of performance testing of injectable products. The article is complementary to In Vitro Release Test Methods for Parenteral Drug Preparations <1001> and takes into account the contents and acknowledges current trends in test apparatus and conditions, medium selection, and separation techniques. Limitations of current practices are presented, and recommendations highlight the need for biorelevant and predictive test environments, test standardization, and an understanding of the impact of the test conditions on the release kinetics and interpretation of test results. dx.doi.org/10.14227/DT290422P204 Reprinted with permission. © 2022 The United States Pharmacopeial Convention. All rights reserved. Correspondence should be addressed to: Desmond G. Hunt, Senior Principal Scientist, Science-General Chapters, US Pharmacopeia, 12601 Twinbrook Parkway, Rockville, MD 20852-1790 email: dgh@usp.org.","PeriodicalId":11380,"journal":{"name":"Dissolution Technologies","volume":"1 1","pages":""},"PeriodicalIF":1.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dissolution Technologies","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.14227/dt290422p204","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 3

Abstract

Performance testing of parenteral products represents a broad arena of product types, test equipment, and analytical challenges. This Stimuli article is one in a series of Stimuli articles on product performance testing focused on common methodological approaches used and challenges encountered in the field of performance testing of injectable products. The article is complementary to In Vitro Release Test Methods for Parenteral Drug Preparations <1001> and takes into account the contents and acknowledges current trends in test apparatus and conditions, medium selection, and separation techniques. Limitations of current practices are presented, and recommendations highlight the need for biorelevant and predictive test environments, test standardization, and an understanding of the impact of the test conditions on the release kinetics and interpretation of test results. dx.doi.org/10.14227/DT290422P204 Reprinted with permission. © 2022 The United States Pharmacopeial Convention. All rights reserved. Correspondence should be addressed to: Desmond G. Hunt, Senior Principal Scientist, Science-General Chapters, US Pharmacopeia, 12601 Twinbrook Parkway, Rockville, MD 20852-1790 email: dgh@usp.org.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
肠外用药产品的体外产品性能:USP专家小组的观点
非注射产品的性能测试代表了产品类型、测试设备和分析挑战的广泛领域。这篇刺激物的文章是刺激物的产品性能测试系列文章中的一篇,重点是常用的方法方法和在注射产品的性能测试领域遇到的挑战。本文是对《肠外药物制剂体外释放试验方法》的补充,考虑了试验设备和条件、介质选择和分离技术的内容和当前趋势。提出了当前实践的局限性,并建议强调需要生物相关和预测性的测试环境,测试标准化,以及对测试条件对释放动力学和测试结果解释的影响的理解。dx.doi.org/10.14227/DT290422P204经许可转载。©2022美国药典公约。版权所有。通信应发送给:Desmond G. Hunt,高级首席科学家,科学总章,美国药典,12601 Twinbrook Parkway, Rockville, MD 20852-1790电子邮件:dgh@usp.org。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Dissolution Technologies
Dissolution Technologies 医学-药学
CiteScore
1.20
自引率
33.30%
发文量
14
审稿时长
3 months
期刊介绍: Dissolution Technologies is a peer reviewed quarterly publication reporting ongoing, useful information on dissolution testing of pharmaceuticals. It provides an international forum for dissolution analysts to receive and exchange information on various dissolution topics. Dissolution Technologies welcomes submissions related to dissolution, in vitro release, and disintegration testing. These topics should be the major focus of the article. Do not submit articles where the focus is formulation development with dissolution testing as one of many tests.
期刊最新文献
Steady-state burning plasma: a new stage in the development of magnetic confinement fusion energy. Investigating the Influence of HPMC K4M and Eudragit L 100-55 on Guanfacine-Loaded Extended-Release Tablets Questions and Answers February 2023 Effect of Mannitol Particle Size on Melatonin Dissolution and Tablet Properties using a Quality by Design Framework Physicochemical Quality and In Vitro Bioequivalence of Amoxicillin Capsules Marketed in Burkina Faso, Africa
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1